Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer

By Linjawi A.   Kontogiannea M.   Halwani F.   Edwardes M.   Meterissian S.  

Journal of the American College of Surgeons, Vol. 198, Iss. 1, 2004-01 ,pp. : 83-90

Elsevier

Access to resources Recommend Favorite

The effects of melatonin and the antioxidant defence system on apoptosis regulator proteins (Bax and Bcl-2) in experimentally induced varicocele

By Onur R.  

Urological Research, Vol. 32, Iss. 3, 2004-06 ,pp. : 204-208

Springer Publishing Company

Access to resources Recommend Favorite

Can Expression of Apoptosis Genes, bcl-2 and bax, Predict Survival and Responsiveness to Chemotherapy in Node-Negative Breast Cancer Patients?

By Kymionis G.D.   Dimitrakakis C.E.   Konstadoulakis M.M.   Arzimanoglou I.   Leandros E.   Chalkiadakis G.   Keramopoulos A.   Michalas S.  

Journal of Surgical Research, Vol. 99, Iss. 2, 2001-08 ,pp. : 161-168

Academic Press

Access to resources Recommend Favorite

p53, bcl-2, and Bax Expression in Renal Cell Carcinoma - immunohistochemical detection of p53 protein versus clinicopathologic parameters

By Vasavada S.P.   Novick A.C.   Williams B.R.G.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 1057-1061

Elsevier

Access to resources Recommend Favorite

bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer - relationship of doubling time to clinical outcome

By Mackey T.J.   Borkowski A.   Amin P.   Jacobs S.C.   Kyprianou N.  

Urology, Vol. 52, Iss. 6, 1998-12 ,pp. : 1085-1090

Elsevier

Access to resources Recommend Favorite